Echinacea Synergy
Natural health product licensed in Canada
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80072965
- Status
- Active licence
- Licence date
- 12 October 2016
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 300 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Perilla frutescens (L.) Britton: Seule l'utilisation du chemotype aldéhyde est autorisée
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Perilla frutescens Source : Graine(s) Extraction ratio : 150:1 Dry plant equivalent : 3,750 milligramme | 25 milligramme | Not calculated |
| Echinacea purpurea Source : Plante Extraction ratio : 3:1 Dry plant equivalent : 900 milligramme | 300 milligramme | Not calculated |
| Vitamine C Source : Acide ascorbique | 100 milligramme | 300,000 µg |
| Vitamine C Source : Ascorbate de magnésium | 100 milligramme | 300,000 µg |
| Vitamine C Source : Ascorbate de sodium | 100 milligramme | 300,000 µg |
| Vitamine C Source : Ascorbate de calcium | 100 milligramme | 300,000 µg |
| Vitamine C Source : Ascorbate de potassium | 100 milligramme | 300,000 µg |
| Vitamine C Source : Palmitate d'ascorbyle | 100 milligramme | 300,000 µg |
| Vitamine C Source : Ascorbate de niacinamide | 100 milligramme | 300,000 µg |
| Zingiber officinale Source : Rhizome Extraction ratio : 8:1 Dry plant equivalent : 200 milligramme | 25 milligramme | Not calculated |
| Glycyrrhiza glabra Source : Racine Potency : 25 % Glycyrrhizin | 50 milligramme | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 8 milligramme | Not calculated |
Non-medicinal ingredients
Bioflavonoïdes d'agrumes, Acide stéarique, Chlorhydrate de L-lysine, L-Glutathione, Hydroxypropylcellulose, Xylitol, Dioxyde de silicium, Cellulose, D-ribose, Pyrophosphate de tétrasodium, Croscarmellose de sodium, NA, Hypromellose, L-cystéine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Echinacea is traditionally used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract. Echinacea is traditionally used in Herbal Medicine to help relieve cold symptoms. Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Helps to relieve the symptoms and shorten the duration of upper respiratory tract infections. Source of antioxidants for the maintenance of good health. Ginger is traditionally used in Herbal Medicine as an expectorant and anti-tussive to help relieve bronchitis as well as coughs and colds. Helps to maintain immune function. Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you are taking immunosuppressants, consult a health care practitioner prior to use. If you have an autoimmune disorder, consult a health care practitioner prior to use. If you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are pregnant. Consult a health care practitioner prior to use if you have a liver disorder.
- Effets indésirables connus
Rare cases of severe allergic reactions have been known to occur; use caution if you are allergic to plants of the Daisy family. Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder.
Source
Official Health Canada record, licence 80072965
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.